top of page
Search


CRISPR-Cas9 Emerges as Promising Tool for Treating Blood Disorders
Published in Cytotherapy Volume 25, Issue 3 (March 2023) A recent review in Cytotherapy highlights how CRISPR-Cas9 gene editing is...
Jul 1, 2025


Immune Cell Therapies Show Promise in Treating Autoimmune Diseases
Published on LinkedIn via Benjamin McLeod Recent research reviewed by Benjamin McLeod highlights significant progress in using immune...
Jun 29, 2025


Early Detection of ‘Bubble Boy Disease’ Saves Newborns in Singapore
Published on The Straits Times Singapore’s expanded newborn screening programme now includes severe combined immunodeficiency (SCID),...
Jun 25, 2025


Mapping the European Regulatory Overlap in ATMP Guidance
Published on Cytotherapy A recent publication in Cytotherapy reviewed 88 European guidance documents related to advanced therapy...
Jun 24, 2025


US Health Leaders Urge Smarter Oversight for Cell and Gene Therapies
Published on HHS (LinkedIn) At a recent roundtable on cell and gene therapies, Health Secretary Robert F. Kennedy Jr., FDA Commissioner...
Jun 21, 2025


Malaysia Unveils National Biotechnology Policy 2.0 to Accelerate Health and Bioeconomy Growth
Published on Ministry of Science, Technology and Innovation (MOSTI) Malaysia has launched the second edition of its National...
Jun 21, 2025


In Vivo CAR-T Delivery Achieves Tumor Control and Immune Reset in Preclinical Models
Published on Science Researchers have demonstrated a method for generating CAR T cells inside the body using CD8-targeted lipid...
Jun 21, 2025


International Coalition Aims to Double CAR‑T Access by 2030
Published on CAR T Vision (via CAR T Vision Coalition website) A new international coalition, CAR T Vision, has launched with a bold...
Jun 21, 2025


Cancer Gene Map Highlights Top Mutations Like P53, PI3K, and BRAF
Published on Spencer Knight via LinkedIn This unique visualization illustrates the prevalence of gene mutations across different parts of...
Jun 17, 2025


2025 Salary Report Shows Rising Pay and Part-Time Leadership Trend in Biotech
Published on Spencer Knight via LinkedIn BioSpace’s 2025 Life Sciences Salary Report highlights key compensation benchmarks in biotech....
Jun 17, 2025


Studies Show CAR-T Therapy Carries Extremely Low Secondary Cancer Risk
Published on Spencer Knight via LinkedIn Concerns about secondary cancers from CAR-T therapy may be overstated, according to new data. A...
Jun 17, 2025


Beyond Cancer: CAR T Therapy Targets Autoimmunity, Infection, and More
Published on Spencer Knight via LinkedIn CAR T-cell therapy has revolutionized oncology, but its next frontier is outside of cancer...
Jun 17, 2025


Gene Therapy Pipeline Reaches Over 1,000 Trials for Rare Diseases
Published on Spencer Knight via LinkedIn There are more than 300 million people worldwide living with rare diseases, many of them with no...
Jun 17, 2025


Gene Editing Landscape: 187 Companies, 3 Focus Areas, and a $17B Market by 2028
Published on Spencer Knight via LinkedIn Spencer Knight shares a compelling visual breakdown of 187 gene editing companies across four...
Jun 17, 2025


From Hype to Hope: CGT Enters the Slope of Enlightenment
Published on Spencer Knight via LinkedIn CAR-T once promised a revolution, then came the cost, complexity, and clinical setbacks. Spencer...
Jun 17, 2025


Sana’s Cell Therapy Restores Insulin Without Immunosuppression: A Game Changer for Type 1 Diabetes
Published on Spencer Knight via LinkedIn Sana Biotechnology has announced successful first-in-human results using HIP-engineered islet...
Jun 17, 2025


Pushing the Limits: How XCell® ATF Hits 200M+ Cells/mL Across Modalities
Published on Repligen Poster, Bioprocessing Summit (July 2023) With biologics becoming more complex and global manufacturing capacity...
Jun 16, 2025


MSD Animal Health Boosts Animal Vaccine Yield with XCell ATF® Intensification
Published on Repligen White Paper (July 2022) Facing growing demand for veterinary vaccines, MSD Animal Health partnered with Repligen to...
Jun 16, 2025


10X Lentivirus Yield With TFDF Perfusion: Scaling CAR-T Manufacturing Without Scaling the Bioreactor
Published on Repligen Application Note (Sept 2024) Lentiviral vector production is a major bottleneck in CAR-T manufacturing, but...
Jun 16, 2025


TFDF Perfusion Boosts AAV and Lentiviral Vector Yields Up to 80-Fold
Published on Repligen Scientific Poster (Sept 2022) To meet growing demand in gene therapy, Repligen scientists applied tangential flow...
Jun 16, 2025
bottom of page
